Article Text

Download PDFPDF
  1. T. R. Magee1,2,3,
  2. J. N. Artaza3,4,
  3. M. G. Ferrini1,2,3,
  4. D. Vernet2,
  5. F. I. Zuniga2,
  6. L. Cantini2,
  7. S. Reisz-Porszasz3,4,
  8. J. Rajfer1,2,
  9. N. F. Gonzalez-Cadavid1,2,3,4
  1. 1Department of Urology, David Geffen School of Medicine, UCLA, Los Angeles, CA
  2. 2Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA
  3. 3College of Science and Health, Drew University of Medicine and Science, Los Angeles, CA
  4. 4Division of Endocrinology Metabolism and Molecular Medicine, RCMI DNA Molecular Core, Charles R. Drew University of Medicine and Science, Los Angeles, CA


Purpose Myostatin negatively regulates skeletal muscle growth. Myostatin-knockout mice exhibit muscle hypertrophy and decreased interstitial fibrosis. We investigated whether a plasmid expressing a short hairpin interfering RNA (shRNA) against myostatin and transduced using electroporation would increase local skeletal muscle mass and reduce interstitial connective tissue.

Methods Short interfering RNAs (siRNAs) targeting myostatin were transfected into HEK293 cells and identified for myostatin silencing by Western blot. Corresponding shRNAs were cloned into plasmid shRNA expression vectors. Myostatin or a randomer negative control shRNA plasmid were injected and electroporated into the tibialis anterior or its contralateral muscle, respectively, of 10 rats that were sacrificed after 2 weeks. Six other rats received a beta-galactosidase reporter plasmid and were sacrificed at 1, 2, and 4 weeks. Uptake of plasmid was examined by beta-galactosidase expression, whereas myostatin expression was determined by real-time PCR and Western blotting. Muscle fiber size and collagen expression were determined by histochemistry. Satellite cell proliferation was determined by PAX7 immunohistochemistry. Myosin heavy chain type II expression was determined by Western blot.

Results Beta-galactosidase reporter plasmid was expressed at 1 and 2 weeks but diminished by 4 weeks. Myostatin shRNA reduced myostatin mRNA and protein expression by 27 and 48%, respectively. Tibialis weight, fiber size, and myosin heavy chain II increased by 10, 34, and 38%, respectively. Satellite cell number was increased by 64%. Interstitial collagen decreased by 40%.

Conclusions This is the first demonstration that myostatin shRNA gene transfer is a potential strategy to increase muscle mass while reducing interstitial connective tissue.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.